FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

698421000168103: Bexsero (meningococcal group B (Neisseria meningitides) adhesin A protein 50 microgram / 0.5 mL + meningococcal group B (Neisseria meningitides) factor H binding protein fusion protein 50 microgram / 0.5 mL + meningococcal group B (Neisseria meningitides) heparin binding antigen fusion protein 50 microgram / 0.5 mL + meningococcal group B (Neisseria meningitides) outer membrane vesicles 25 microgram / 0.5 mL) injection suspension, 0.5 mL syringe (trade product unit of use)


    Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module

    Descriptions:

    Id Description Lang Type Status Case? Module
    1405601000168116 Bexsero (meningococcal group B (Neisseria meningitides) adhesin A protein 50 microgram / 0.5 mL + meningococcal group B (Neisseria meningitides) factor H binding protein fusion protein 50 microgram / 0.5 mL + meningococcal group B (Neisseria meningitides) heparin binding antigen fusion protein 50 microgram / 0.5 mL + meningococcal group B (Neisseria meningitides) outer membrane vesicles 25 microgram / 0.5 mL) injection suspension, 0.5 mL syringe (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
    1405611000168118 Bexsero injection suspension, 0.5 mL syringe en Synonym Active Case sensitive Australian Medicines Terminology module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Bexsero injection suspension, 0.5 mL syringe has intended active ingredient meningococcal group B adhesin A protein false Inferred relationship Some 78493194
    Bexsero injection suspension, 0.5 mL syringe has intended active ingredient meningococcal group B (Neisseria meningitides) outer membrane vesicles (AU substance) false Inferred relationship Some 1579575948
    Bexsero injection suspension, 0.5 mL syringe has intended active ingredient meningococcal group B (Neisseria meningitides) factor H binding protein fusion protein (AU substance) false Inferred relationship Some 1018683716
    Bexsero injection suspension, 0.5 mL syringe has Australian BoSS meningococcal group B (Neisseria meningitides) outer membrane vesicles (AU substance) false Inferred relationship Some 1579575948
    Bexsero injection suspension, 0.5 mL syringe Is a trade product unit of use false Inferred relationship Some
    Bexsero injection suspension, 0.5 mL syringe Is a Bexsero false Inferred relationship Some
    Bexsero injection suspension, 0.5 mL syringe Is a meningococcal group B heparin binding antigen fusion protein 50 microgram/0.5 mL + meningococcal group B adhesin A protein 50 microgram/0.5 mL + meningococcal group B factor H binding protein fusion protein 50 microgram/0.5 mL + meningococcal group B outer membrane vesicles 25 microgram/0.5 mL injection, syringe false Inferred relationship Some
    Bexsero injection suspension, 0.5 mL syringe has manufactured dose form injection suspension false Inferred relationship Some
    Bexsero injection suspension, 0.5 mL syringe has Australian BoSS meningococcal group B heparin binding antigen fusion protein false Inferred relationship Some 513436470
    Bexsero injection suspension, 0.5 mL syringe has Australian BoSS meningococcal group B (Neisseria meningitides) factor H binding protein fusion protein (AU substance) false Inferred relationship Some 1018683716
    Bexsero injection suspension, 0.5 mL syringe has intended active ingredient meningococcal group B heparin binding antigen fusion protein false Inferred relationship Some 513436470
    Bexsero injection suspension, 0.5 mL syringe has Australian BoSS meningococcal group B adhesin A protein false Inferred relationship Some 78493194
    Bexsero injection suspension, 0.5 mL syringe has unit of use syringe false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Bexsero injection suspension, 0.5 mL syringe has TPUU False Bexsero injection suspension, 0.5 mL syringe Inferred relationship Some
    Bexsero injection suspension, 10 x 0.5 mL syringes has TPUU False Bexsero injection suspension, 0.5 mL syringe Inferred relationship Some
    Bexsero injection suspension, 10 x 0.5 mL syringes has TPUU False Bexsero injection suspension, 0.5 mL syringe Inferred relationship Some
    Bexsero (meningococcal group B (Neisseria meningitides) adhesin A protein 50 microgram / 0.5 mL + meningococcal group B (Neisseria meningitides) factor H binding protein fusion protein 50 microgram / 0.5 mL + meningococcal group B (Neisseria meningitides) heparin binding antigen fusion protein 50 microgram / 0.5 mL + meningococcal group B (Neisseria meningitides) outer membrane vesicles 25 microgram / 0.5 mL) injection suspension, 1 x 0.5 mL syringe (containered trade product pack) has TPUU False Bexsero injection suspension, 0.5 mL syringe Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    REPLACED BY association reference set

    Back to Start